Viridian Therapeutics Inc Ordinary Shares VRDN 深 沪
已收盘 09-19 16:00:00 美东时间
22.50
+1.440
+6.84%
华盛通- 最 高22.53
- 今 开21.75
- 成交量 171.72万股
- 最 低 21.55
- 昨 收 21.06
- 总市值 17.18亿
- 52周最高 24.18
- 市盈率 静 --
- 换手率 2.25%
- 52周最低 10.925
- 委 比 -98.39%
- 总股本 7635.65万
- 历史最高 270.00
- 量 比 0.64
- 振 幅 4.65%
- 历史最低 4.665
- 每 手 1
- 风险率 3.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多RBC Capital Reiterates Outperform on Viridian Therapeutics, Maintains $44 Price Target
RBC Capital analyst Gregory Renza reiterates Viridian Therapeutics (NASDAQ:VRDN) with a Outperform and maintains $44 price target.
09-19 22:11
ANI Pharmaceuticals completes purchase of Alimera Sciences
ANI Pharmaceuticals (ANIP) said it completed its planned acquisition of Alimera Sciences (NASDAQ:ALIM). Under the terms of the merger agreement, ANI acquired all of the outstanding shares of Alimera...
09-16 21:04
快讯 | Viridian Therapeutics 公司：RBC将目标价从35美元上调至44美元
Viridian Therapeutics Inc : RBC Raises Target Price to $44 From $35
09-13 13:53
Viridian Therapeutics slides on pricing $225M securities offering
Viridian Therapeutics (NASDAQ:VRDN) shares dropped 2% after-hours on Wednesday after the biotechnology company priced an upsized underwritten public offering of common stock and preferred stock, compr...
09-12 14:12
美股牛股 | 生物制药公司SMMT再涨20%，近两个交易日累涨87%；康丽数码飙升20%
新药疗效击败默沙东！生物制药公司SMMT再涨20%，近两个交易日累涨87%；宣布启动1亿美元股票回购计划，康丽数码飙升20%>>
09-11 19:14
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated to education, recovery centers, and outreach initiatives.
09-11 02:09
Rubrik's Q2 results, guidance, indicate 'solid progress on efficient growth,' Baird says
Rubrik's (NYSE:RBRK) second-quarter results and raised guidance are indicative that the company is making "solid progress on efficient growth," investment firm Baird said. Shares fell 5% in midday tra...
09-11 01:47
Buy Rating Affirmed: Viridian Therapeutics’ Phase 3 Success and Market Potential
Analyst Jason Butler of JMP Securities reiterated a Buy rating on Viridian Ther...
09-11 00:45
Oracle pops on earnings and takes many ETFs higher with it
Shares of Oracle (NYSE:ORCL) popped over 11% on Tuesday after the computer software firm provided investors with fiscal first quarter results that surpassed estimates. While the Texas headquartered co...
09-10 23:50
JPMorgan stock gaps down as Pinto says analyst estimates are too optimistic
JPMorgan Chase (NYSE:JPM) stock slid 6.2% in Tuesday morning trading as Daniel Pinto, the bank's president and chief operating officer, said next year's net interest income "will be lower" than what a...
09-10 23:07
